title: Efficacy of rituximab treatment in postpartum acquired haemophilia A.
authors.forename: C
authors.initials: C
authors.lastname: Santoro
authors.forename: A
authors.initials: A
authors.lastname: Rago
authors.forename: F
authors.initials: F
authors.lastname: Biondo
authors.forename: M S
authors.initials: MS
authors.lastname: De Propris
authors.forename: A
authors.initials: A
authors.lastname: De Vellis
authors.forename: A
authors.initials: A
authors.lastname: Guarini
authors.forename: P
authors.initials: P
authors.lastname: Pignoloni
authors.forename: M G
authors.initials: MG
authors.lastname: Mazzucconi
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood* / Q000187:drug effects; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D049590:Postpartum Period / Q000097:blood; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D000069283:Rituximab